DCGI expert panel meet today to review the Phase III data of Bharat Biotech’s Covaxin – KEY EXPECTATIONS

0 40

The Subject Expert Committee (SEC) under the drug regulator will meet on Tuesday, June 22 to review the Phase III data of Bharat Biotech’s Covaxin.

Leave A Reply

Your email address will not be published.